Emergex Secures State-of-the-Art R&D Facility and Hires a Chief Scientific Officer to Drive Development of Its Vaccines
OXFORD, England--(BUSINESS WIRE)--Feb 18, 2019--Emergex Vaccines Holding Limited ('Emergex'), a biotechnology company pioneering a novel approach to the development of vaccines for…
